examin
whether
investor
mood
driven
world
health
organ
alert
media
news
danger
infecti
diseas
price
pharmaceut
compani
stock
unit
state
argu
diseaserel
news
drn
trigger
ration
trade
find
drn
posit
signific
sentiment
effect
among
investor
wall
street
effect
stronger
weaker
small
larg
compani
less
like
engag
develop
new
vaccin
potenti
neg
investor
climat
main
street
induc
diseaserel
feardo
alter
posit
sentiment
effect
asset
price
literatur
varieti
mood
variabl
consid
instanc
weather
condit
saunder
hirshleif
shumway
hour
daylight
fall
winter
kamstra
et
al
intern
soccer
result
edman
et
al
kaplanski
levi
curatola
et
al
neg
newspap
articl
tetlock
notabl
investor
sentiment
found
signific
impact
stock
market
return
mehra
sah
relat
theoret
framework
effect
feel
investor
decis
make
financi
market
nofsing
find
interperson
commun
lead
social
mood
translat
emot
optim
pessim
happi
anxieti
gener
find
fear
lead
neg
asset
return
posit
emot
increas
investor
willing
take
risk
studi
hypothes
increas
media
coverag
danger
infecti
diseas
posit
rel
persist
effect
pharmaceut
stock
despit
overal
neg
sentiment
popul
due
fear
infect
public
polit
demand
contain
infecti
diseas
lead
addit
incom
channel
pharmaceut
compani
typic
reaction
infecti
ill
includ
higher
r
invest
partial
subsid
govern
vaccin
mass
order
gener
increas
demand
prevent
measur
eg
medicin
disinfect
agent
surgic
mask
focu
four
major
infecti
diseas
regard
public
health
emerg
intern
concern
pheic
outbreak
sever
acut
respiratori
syndrom
sar
influenza
polio
ebola
less
intens
cover
media
role
mass
media
commun
potenti
risk
subject
intens
debat
argu
lowprob
highconsequ
event
potenti
health
risk
associ
outbreak
rare
diseas
overemphas
mediagener
news
wave
unbalanc
report
lead
disjunct
actual
peopl
perceiv
risk
vasterman
et
al
mairal
young
et
al
instanc
repres
survey
conduct
blendon
et
al
indic
respond
live
ontario
canada
exclud
ontario
u
concern
contract
sar
wherea
educ
inform
commun
effort
singapor
result
much
lower
overal
anxieti
level
quah
hinpeng
report
respond
view
sar
person
risk
may
public
overreact
panic
also
lead
advers
econom
effect
particular
sector
tourism
retail
sale
fall
due
individu
prevent
measur
reduct
travel
affect
area
avoid
public
place
case
sar
hanna
yipe
estim
total
cost
gdp
china
keogh
brown
smith
assess
global
econom
impact
billion
usd
billion
usd
use
gener
equilibrium
model
uk
smith
et
al
estim
cost
relat
influenza
uk
gdp
howev
total
econom
burden
difficult
quantifi
sinc
direct
health
care
cost
well
indirect
cost
work
absente
loss
product
taken
account
spirit
kaplanski
levi
search
media
articl
relat
danger
infecti
diseas
order
gain
better
understand
scale
time
inform
salienc
diseas
ii
evalu
import
inform
salienc
potenti
sourc
investor
sentiment
pharmaceut
industri
fig
illustr
normal
number
media
news
inform
gener
public
diseas
outbreak
mention
four
evid
fig
frequenc
relat
news
notabl
increas
announc
day
note
figur
depict
normal
number
distinct
diseaserel
newspap
articl
publish
us
around
event
day
event
date
consid
offici
pheic
statement
number
articl
reli
four
diseas
announc
normal
rel
peak
valu
period
dot
line
repres
averag
rel
valu
across
period
black
diamond
illustr
absolut
number
diseaserel
newspap
articl
data
obtain
use
lexisnexi
databas
global
news
busi
inform
offici
pheic
statement
made
news
coverag
intensifi
peak
third
day
offici
pheic
announc
addit
absolut
number
news
announc
remain
averag
six
day
announc
surpris
sinc
pheic
statement
follow
officialinstitut
news
use
build
eventday
mood
variabl
next
section
specif
two
four
case
event
ie
drn
take
place
six
day
follow
pheic
announc
observ
provid
support
exist
rel
strong
relat
offici
news
media
coverag
therefor
drn
investor
sentiment
moreov
suggest
sentiment
effect
last
sever
day
evid
provid
support
persist
sentiment
hypothesi
formul
section
pharmaceut
industri
heart
us
economi
although
public
privat
spend
pharmaceut
us
collect
contribut
around
usd
countri
gdp
per
capita
oecd
share
largest
among
oecd
countri
overal
us
health
care
expenditur
account
countri
gdp
estim
contribut
furthermor
biopharmaceut
compani
us
account
largest
share
us
compani
r
expenditur
repres
nearli
domest
r
phrma
one
fastest
grow
industri
inde
revenu
r
spend
us
biopharmaceut
industri
tripl
lazonick
tulum
offit
document
increas
market
concentr
vaccin
produc
us
past
decad
specif
current
four
fdaapprov
usbas
publicli
trade
vaccin
produc
distributor
reason
compani
undertak
quit
vaccin
product
multifold
one
hand
research
develop
test
manufactur
vaccin
costli
hand
market
sell
vaccin
smaller
market
pharmaceut
drug
name
reason
howev
high
entri
barrier
develop
new
vaccin
bear
potenti
monopoli
addit
manufactur
gener
vaccin
vaccin
product
substanti
complic
technolog
advanc
drug
product
result
increas
vaccin
shortag
especi
flu
vaccin
hinman
et
al
emerg
danger
infecti
diseas
thu
regard
potenti
new
market
vaccin
produc
along
subsid
r
therefor
surpris
research
focus
effect
investor
sentiment
stock
price
pharmaceut
compani
underwhelm
studi
focu
us
stock
market
two
main
reason
select
us
stock
market
studi
one
close
follow
market
world
effici
respect
new
inform
also
liquid
market
kaplanski
levi
us
stock
market
one
lead
stock
market
world
account
global
market
hou
et
al
studi
motiv
grow
role
pharmaceut
stock
within
industri
financi
servic
unit
state
percept
life
scienc
offshor
fund
million
usd
traxi
sivik
global
healthcar
offshor
million
usd
visium
balanc
offshor
fund
million
usd
exampl
sectorspecif
equiti
fund
invest
exclus
biopharmaceut
stock
also
larg
number
fund
signific
exposur
stock
main
individu
pharmaceut
compani
inde
tabl
indic
second
quarter
institut
investor
held
signific
posit
largest
pharmaceut
firm
stock
includ
pfizer
johnson
johnson
merck
compani
astrazeneca
amgen
gilead
scienc
inc
section
briefli
describ
drn
collect
procedur
construct
pharmaceut
portfolio
data
cover
entir
histori
danger
infecti
diseas
consid
pheic
whoa
statement
offici
statement
commun
public
regard
new
substanti
inform
relat
certain
diseas
instanc
august
statement
meet
ihr
emerg
committe
ebola
outbreak
west
africa
inform
current
state
ebola
outbreak
addit
emerg
committe
state
condit
pheic
met
provid
advic
address
ebola
outbreak
affect
countri
typic
popular
media
use
statement
commun
news
public
diseas
outbreak
news
hand
extent
regular
updat
current
situat
includ
instanc
news
first
crossbord
transmiss
diseas
case
sar
outbreak
period
daili
updat
news
influenza
outbreak
cover
weekli
basi
recogn
regularli
space
updat
may
anticip
stock
market
investor
may
price
prior
actual
updat
reason
sampl
announc
compris
updat
document
firsttim
crossbord
transmiss
strategi
help
ensur
independ
subsequ
announc
insofar
crossbord
transmiss
infecti
diseas
occur
unpredict
case
sar
observ
rapid
spread
across
countri
within
first
two
month
total
countri
affect
diseas
case
influenza
offici
list
contain
countri
oversea
territori
commun
august
viru
spread
quickli
list
includ
sizabl
number
first
crossbord
transmiss
date
around
polio
abstain
identifi
first
outbreak
date
event
date
total
consid
ebola
count
crossbord
transmiss
total
howev
diseas
control
time
paper
written
addit
statement
diseas
outbreak
news
includ
releas
date
offici
statement
provid
govern
ministri
agenc
well
individu
publicli
trade
compani
newli
develop
vaccin
subject
government
approv
posit
feedback
might
substanti
impact
share
price
vaccin
produc
compani
well
competitorsfollow
use
offici
press
releas
date
provid
websit
us
depart
health
human
servic
hh
label
approv
categori
relev
influenza
sar
ebola
vaccin
still
develop
potent
polio
vaccin
exist
decad
govern
order
govern
order
cancel
refer
govern
purchas
vaccin
subsequ
cancel
order
date
refer
influenza
outbreak
case
sar
outbreak
compani
grant
research
fund
develop
potent
vaccin
label
offici
date
fund
announc
occasion
fals
alarm
countri
temporarili
includ
subsequ
remov
list
affect
countri
sar
outbreak
could
confirm
retrospect
also
includ
fals
alarm
date
analysi
sinc
public
like
take
inform
fact
without
question
reliabl
time
public
research
fund
categori
statement
subsum
differ
potenti
influenti
statement
provid
govern
offici
compani
refer
current
situat
regard
diseas
drn
classifi
summar
tabl
appendix
stock
market
data
endoftradingday
price
market
valu
retriev
thomson
reuter
datastream
crosssect
includ
pharmaceut
compani
list
either
new
york
stock
exchang
nyse
nation
associ
secur
dealer
autom
quotat
nasdaq
pharmaceut
compani
list
tabl
appendix
addit
retriev
p
inform
technolog
index
nonu
base
compani
use
data
american
depositori
receipt
adr
give
rise
period
trade
day
januari
novemb
test
impact
drn
pharmaceut
stock
return
employ
rate
return
varieti
portfolio
compris
pharmaceut
stock
specif
construct
four
benchmark
pharmaceut
portfolio
first
equal
weight
portfolio
ew
ew
portfolio
draw
literatur
optim
portfolio
investor
de
miguel
et
al
second
valueweight
portfolio
pharmaceut
stock
timevari
marketvalu
base
weight
vw
third
portfolio
constantvalueweight
portfolio
account
largest
pharmaceut
stock
top
fourth
constantvalueweight
portfolio
smallest
pharmaceut
stock
bottom
vw
portfolio
emphas
role
larg
compani
oppos
small
compani
top
portfolio
illustr
realworld
situat
investor
constrain
cardin
constraint
bottom
portfolio
address
hypothesi
state
next
section
final
inclus
p
inform
technolog
index
p
standard
tradabl
diversifi
portfolio
stock
seek
project
hypothes
sector
pharmaceut
show
drn
posit
sentiment
spread
sector
confirm
breadth
sentiment
confin
pharmaceut
industri
comput
continu
compound
daytoday
percentag
return
aforement
portfolio
descript
statist
present
tabl
sampl
period
mean
return
vw
portfolio
pharmaceut
stock
timevari
weight
consider
greater
mean
remain
portfolio
median
follow
similar
pattern
one
notabl
except
differ
mean
median
henc
ensu
asymmetri
probabl
densiti
function
largest
ew
portfolio
rang
variat
maximum
minimum
return
greatest
p
portfolio
respect
lowest
vw
portfolio
respect
bottom
portfolio
highest
idiosyncrat
risk
measur
standard
deviat
wherea
top
portfolio
least
riski
invest
moreov
portfolio
return
neg
skew
except
vw
portfolio
neg
skew
impli
larg
neg
return
like
larg
posit
return
furthermor
return
five
portfolio
leptokurt
coeffici
excess
kurtosi
greater
zero
high
valu
excess
kurtosi
contribut
observ
nonnorm
return
five
portfolio
measur
jarquebera
test
statist
ljungbox
test
statist
provid
evid
serial
correl
squar
return
therefor
regressionbas
methodolog
section
design
account
heteroscedast
note
tabl
report
descript
statist
continu
compound
daytoday
percentag
return
five
invest
portfolio
ew
denot
return
equal
weight
portfolio
pharmaceut
stock
vw
denot
return
timevari
valueweight
portfolio
pharmaceut
stock
top
denot
return
constantvalueweight
portfolio
largest
pharmaceut
firm
bottom
denot
return
constantvalueweight
portfolio
smallest
pharmaceut
stock
p
denot
return
p
inform
technolog
index
q
denot
ljungbox
test
statist
fifthord
cumul
autocorrel
stock
return
q
denot
ljungbox
test
statist
fifthord
cumul
autocorrel
return
squar
tabl
also
provid
pvalu
signific
test
jarquebera
ljungbox
statist
parenthes
use
daili
data
period
total
observ
section
outlin
testabl
hypothes
pharmaceut
stock
return
around
drn
drn
may
give
rise
two
conflict
sentiment
effect
drn
posit
effect
fear
effect
respect
kaplanski
levi
document
neg
signific
war
sentiment
effect
arabisra
war
israel
posit
signific
holiday
sentiment
effect
firstli
drn
may
lead
anxieti
bad
mood
pessim
among
gener
public
stock
market
investor
associ
panic
effect
gener
overemphas
media
coverag
danger
infecti
diseas
scenario
anxieti
fear
spread
across
differ
stock
market
sector
may
instig
drop
pharmaceut
stock
price
hypothesi
posit
investor
fear
gaug
provok
drn
may
lead
decreas
rate
return
pharmaceut
stock
hypothesi
drn
may
lead
bad
mood
among
investor
may
neg
affect
portfolio
return
pharmaceut
stock
secondli
danger
infecti
diseas
may
perceiv
investor
profit
invest
opportun
unreason
anticip
diseas
trigger
increas
r
expenditur
pharmaceut
compani
develop
gener
posit
sentiment
henc
rais
demand
pharmaceut
stock
result
portfolio
valuat
increas
thu
hypothesi
posit
posit
relat
drn
return
pharmaceut
stock
hypothesi
drn
posit
effect
portfolio
return
pharmaceut
stock
third
hypothesi
predict
investor
initi
underreact
announc
danger
infecti
diseas
overreact
thereaft
degre
overreact
depend
announc
rel
salienc
measur
media
coverag
palomino
et
al
klibanoff
et
al
report
larger
inform
salienc
announc
faster
content
incorpor
closedend
countri
fund
price
within
pharmaceut
industri
consider
media
coverag
caus
signific
chang
stock
price
continu
overreport
even
though
genuin
new
inform
becom
avail
market
huberman
regev
thu
motiv
literatur
observ
inflow
inform
around
pheic
alert
see
fig
posit
hypothesi
posit
sentiment
stock
market
investor
remain
elev
level
event
hypothesi
drn
persist
effect
portfolio
return
pharmaceut
stock
persist
consist
inflow
diseaserel
inform
stock
market
fourth
hypothesi
build
notion
investor
sentiment
affect
small
cap
stock
stronger
rel
larg
cap
stock
brown
cliff
therefor
expect
event
day
investor
sentiment
potenti
stronger
small
pharmaceut
firm
larg
firm
hypothesi
support
recent
studi
suggest
stock
small
firm
mainli
held
local
investor
tend
larg
influenc
specif
event
edman
et
al
furthermor
even
though
larg
pharmaceut
compani
act
forerunn
r
activ
may
less
costli
small
pharmaceut
compani
act
follow
develop
new
drug
howev
vaccin
product
requir
costli
sophist
technolog
drug
product
hinman
et
al
cost
develop
effect
new
vaccin
place
constraint
small
pharmaceut
firm
result
like
develop
new
vaccin
less
frequent
larg
firm
thu
posit
hypothesi
investor
sentiment
driven
drn
larger
effect
price
small
pharmaceut
stock
comparison
larg
stock
hypothesi
drn
greater
effect
stock
return
small
compani
rel
larg
compani
two
commonli
usedth
eventstudi
regressionbasedmethodolog
use
test
hypothes
spirit
tradit
event
studi
begin
analysi
comput
cumul
abnorm
return
car
around
drn
abnorm
return
defin
differ
observ
rate
return
pharmaceut
portfolio
expost
expect
rate
return
whole
length
event
window
expect
rate
return
estim
base
famafrench
threefactor
model
choos
event
window
length
cover
day
prior
day
drn
estim
window
model
day
long
sampl
observ
tempor
cluster
drn
mean
drn
taken
account
car
would
despit
welldocu
firstmov
advantag
pharmaceut
industri
current
law
chemic
formula
efficaci
cure
establish
clinic
trial
made
avail
competitor
essenti
free
boldrin
levin
p
patent
expir
lowcost
gener
immedi
introduc
market
daili
data
factor
smb
hml
excess
return
market
obtain
kenneth
french
websit
http
mbatuck
dartmouthedupagesfacultykenfrench
suffer
overlap
event
window
reason
car
calcul
includ
subset
avail
drn
drn
select
accord
follow
two
criteria
first
select
procedur
last
event
choos
drn
follow
drn
within
day
occurr
first
event
hand
select
drn
chronolog
order
start
first
drn
sampl
ignor
drn
show
proxim
day
take
next
drn
success
ignor
follow
day
iter
proce
whole
sampl
exhaust
illustr
assum
five
drn
take
place
date
tempor
cluster
last
event
use
drn
car
calcul
occur
day
first
event
choos
panel
b
fig
illustr
two
simpl
exampl
follow
exist
empir
studi
kamstra
et
al
edman
et
al
kaplanski
levi
b
curatola
et
al
evalu
impact
drn
pharmaceut
stock
return
identifi
neg
fear
effect
thu
implement
follow
regress
model
r
p
daili
rate
return
pharmaceut
stock
portfolio
p
time
regress
intercept
lag
depend
variabl
dummi
variabl
monday
tuesday
wednesday
thursday
respect
tax
dummi
variabl
first
five
day
taxat
year
e
repres
drn
effect
variabl
fi
denot
fear
index
u
p
error
term
line
exist
studi
vix
use
proxi
invest
fear
index
also
known
investor
fear
gaug
whaley
specif
spirit
bloom
note
figur
depict
averag
cumul
residu
around
event
date
pharmaceut
portfolio
ew
vw
top
bottom
residu
day
calcul
differ
observ
rate
return
expost
expect
rate
return
day
threefactor
model
r
pharmaceut
portfolio
return
r
r
f
smb
hml
famafrench
factor
estim
window
day
solid
dash
line
repres
last
first
event
approach
estim
car
ensur
event
window
nonoverlap
panel
b
illustr
two
differ
estim
procedur
graphic
last
first
event
approach
includ
event
day
estim
procedur
event
occur
period
march
includ
event
day
nonoverlap
event
window
consid
vix
adequ
proxi
correl
roll
standard
deviat
p
index
p
pharma
portfolio
rather
high
averag
correl
report
parenthes
ew
vw
top
bottom
fear
effect
fi
overlap
sentiment
effect
gener
drn
case
variabl
embed
main
regress
account
possibl
serial
correl
choos
five
lag
return
sure
serial
correl
account
dummi
variabl
day
week
employ
account
socal
monday
effect
account
possibl
posit
sentiment
effect
day
follow
drn
differ
possibl
revers
effect
run
also
follow
regress
approach
last
event
approach
give
rise
posit
abnorm
return
follow
event
day
ew
bottom
portfolio
increas
prior
event
attribut
sensit
last
event
approach
contigu
preced
event
overlap
window
first
event
approach
point
increas
return
ew
bottom
portfolio
event
day
increas
rather
persist
day
follow
event
thu
confirm
drn
discard
car
calcul
posit
impact
pharmaceut
stock
return
result
less
support
vw
top
portfolio
event
studi
result
weaker
regress
result
report
next
section
due
fact
drn
employ
car
analysi
gener
ew
lastfirst
vw
top
bottom
experienc
event
case
signific
car
level
car
analysi
provid
evid
support
persist
posit
sentiment
effect
hypothesi
hypothesi
one
could
anticip
smb
factor
threefactor
famafrench
model
alreadi
captur
effect
invest
sentiment
bias
estim
car
inde
investor
hold
smaller
cap
stock
becom
optimist
smb
factor
increas
car
decreas
also
comput
car
employ
excess
return
market
onefactor
model
unreport
result
suggest
pronounc
car
bottom
portfolio
overal
event
studi
analysi
reveal
posit
persist
effect
drn
stock
return
pharmaceut
compani
result
examin
effect
fear
gaug
drn
pharmaceut
stock
market
return
report
tabl
panel
document
main
find
result
incorpor
event
regress
analysi
robust
purpos
also
rerun
model
subsampl
drn
employ
whorel
announc
see
panel
b
consist
hypothesi
neg
signific
effect
fear
gaug
index
obtain
effect
robust
across
five
portfolio
estim
coeffici
rang
top
portfolio
vw
portfolio
thu
effect
investor
fear
gaug
strongest
diversifi
portfolio
stock
weakest
larg
firm
drn
variabl
effect
alway
posit
gener
signific
level
vindic
hypothesi
coeffici
estim
rang
vw
p
thu
wake
drn
stock
return
increas
roughli
bp
interest
find
insofar
diseas
outbreak
ebola
may
actual
spread
unit
state
howev
investor
decis
guid
sentiment
paradox
danger
infecti
diseas
may
impos
nonneglig
cost
economi
may
potenti
lead
deplet
resourc
drn
produc
optimist
view
posit
sentiment
effect
among
us
investor
unreason
anticip
pharmaceut
compani
whose
stock
adr
list
nyse
nasdaq
invest
r
potenti
rais
futur
cash
flow
howev
investor
overlook
fact
patent
system
impos
constraint
invest
product
growth
pharmaceut
industri
boldrin
levin
time
underestim
probabl
vaccin
medicin
necessarili
effect
shortridg
result
unambigu
indic
investor
buy
stock
infecti
diseas
outbreak
announc
moreov
invest
portfolio
domin
larg
cap
stock
top
vw
diseas
outbreak
announc
yield
lower
return
invest
portfolio
small
cap
stock
bottom
ceteri
paribu
find
support
hypothesi
wherein
small
cap
stock
respond
stronger
investor
sentiment
larg
cap
stock
result
agre
brown
cliff
edman
et
al
tabl
show
investor
fear
gaug
smallest
largest
effect
absolut
valu
top
vw
portfolio
respect
investor
fear
gaug
reflect
investor
pessim
regard
portfolio
invest
neg
effect
stock
price
return
pharmaceut
compani
result
confirm
hypothesi
onefactor
model
ew
lastfirst
vw
top
bottom
experienc
event
case
signific
car
level
either
due
lower
expens
relat
subcontract
assid
et
al
less
costli
imit
larger
pharmaceut
compani
boldrin
levin
small
pharmaceut
stock
potenti
gener
higher
return
larg
stock
regress
result
drn
fear
effect
const
regress
result
drn
contemporan
lag
effect
fear
effect
const
result
regress
continu
compound
daytoday
percentag
return
equal
weight
portfolio
pharmaceut
stock
ew
valueweight
portfolio
vw
constantvalueweight
portfolio
largest
pharmaceut
stock
top
constantvalueweight
portfolio
smallest
pharmaceut
stock
bottom
p
inform
technolog
index
p
report
vw
comput
use
timevari
weight
wherea
top
bottom
comput
use
constant
weight
base
initi
market
capit
e
repres
drn
contemporan
lag
effect
variabl
tabl
panel
e
compos
drn
panel
b
e
compos
diseas
outbreak
news
statement
loglikelihood
valu
estim
model
shown
last
column
pvalu
parenthes
eickerwhit
standard
error
estim
robust
heteroscedast
use
daili
data
period
total
observ
n
signific
level
nn
signific
level
nnn
signific
level
posit
neg
relat
investor
fear
gaug
return
pharmaceut
stock
qualit
similar
result
report
kaplanski
levi
wherein
investor
fear
gaug
provok
arabisra
war
respons
neg
effect
stock
market
return
tel
aviv
stock
exchang
tabl
also
indic
investor
sentiment
effect
posit
persist
use
six
lag
drn
captur
persist
number
lag
dictat
fig
indic
number
media
articl
remain
averag
six
day
pheic
event
thu
expect
posit
sentiment
effect
last
six
day
due
continu
flow
inform
stock
market
test
combin
effect
contemporan
lag
drn
pharmaceut
stock
return
end
test
signific
coeffici
sum
entri
relat
coeffici
sum
highlight
drn
posit
sentiment
effect
stronger
among
small
pharmaceut
firm
weaker
vw
portfolio
case
coeffici
signific
level
estim
lag
effect
consist
kaplanski
levi
argu
announc
typic
receiv
headlin
sever
day
event
estim
result
five
portfolio
show
posit
signific
effect
level
least
six
trade
day
drn
releas
thu
result
also
support
hypothesi
wherein
posit
investor
sentiment
remain
signific
sever
day
drn
result
agre
huberman
regev
underscor
import
inform
salienc
breakthrough
biopharmaceut
research
contemporan
lag
effect
provid
unequivoc
evid
drn
posit
signific
either
contemporan
lag
effect
pharmaceut
stock
price
fear
gaug
drn
provok
chang
pharmaceut
stock
price
also
p
industri
unrel
danger
infecti
diseas
thu
lend
support
invest
sentiment
effect
specif
result
indic
fear
gaug
drn
alway
neg
posit
signific
effect
stock
return
p
result
show
investor
sentiment
effect
widespread
across
variou
industri
lead
profit
trade
strategi
valid
research
find
number
robust
check
first
examin
extent
investor
sentiment
spread
sector
economi
even
countri
regard
presenc
investor
sentiment
identifi
p
industri
index
industri
seemingli
unrel
danger
infecti
diseas
impact
fear
gaug
drn
also
test
region
directli
affect
four
danger
infecti
diseas
particular
estim
result
show
neg
posit
signific
effect
fear
gaug
drn
return
msci
emerg
market
stock
market
index
second
account
presenc
condit
heteroscedast
daili
stock
return
regress
methodolog
extend
includ
batteri
garch
specif
benchmark
methodolog
result
show
neg
posit
signific
effect
fear
gaug
drn
pharmaceut
stock
return
endors
main
find
third
complementari
exercis
vari
number
lag
eq
estim
result
broadli
support
hypothesi
fourth
perform
regress
exclud
control
variabl
ie
drn
fear
gaug
variabl
main
find
upheld
gener
conclus
drawn
robust
check
investor
sentiment
trigger
danger
infecti
diseas
neither
confin
pharmaceut
industri
modelspecif
contrast
presenc
investor
sentiment
robust
type
activ
geograph
scope
variou
methodolog
underpin
empir
evid
assert
investor
will
exploit
sentiment
fear
effect
respons
drn
build
leverag
posit
pharmaceut
stock
purpos
consid
zerocost
strategi
event
day
coincid
highvolatil
period
measur
fear
index
zerocost
spread
portfolio
take
long
posit
one
four
mention
pharmaceut
portfolio
short
posit
vix
assum
invest
horizon
spread
portfolio
vari
one
day
three
day
elimin
timinginconsist
trade
initi
close
price
event
day
procedur
ensur
trade
preced
drn
public
given
event
day
tabl
report
strategi
averag
perform
panel
result
drn
panel
b
report
whorel
subsampl
strategi
yield
signific
perform
four
pharmaceut
portfolio
differ
hold
period
two
three
day
remark
profit
profit
higher
case
ew
bottom
portfolio
longer
term
profit
overweight
pharmaceut
stock
underweight
vix
illustr
fig
differ
zerocost
spread
portfolio
whose
profit
summar
tabl
assum
investor
hold
benchmark
portfolio
fulli
expos
stock
market
tranquil
time
investor
wealth
invest
market
portfolio
proxi
p
event
day
coincid
high
volatil
period
investor
realloc
fund
go
long
pharmaceut
portfolio
short
vix
hold
posit
one
three
day
depict
outperform
calcul
differ
cumul
perform
trade
strategi
market
portfolio
visual
inspect
suggest
similar
addit
check
report
avail
author
upon
request
precis
approach
would
involv
exact
public
time
news
given
countri
consid
time
zone
differ
us
respect
countri
unfortun
drn
time
stamp
nevertheless
trade
strategi
consist
time
drn
accompani
exact
public
time
note
figur
depict
outperform
portfolio
follow
drnsbase
trade
strategi
strategi
initi
long
posit
pharmaceut
portfolio
use
close
price
drn
day
short
posit
vix
event
date
coincid
highvolatil
state
world
indic
fear
index
tranquil
time
ie
absenc
drn
investor
wealth
invest
market
portfolio
proxi
p
event
day
coincid
high
volatil
period
investor
realloc
fund
go
long
pharmaceut
portfolio
short
vix
hold
posit
one
day
perform
vw
top
portfolio
ew
bottom
profit
strategi
three
invest
horizon
except
period
panel
robust
purpos
ignor
fear
effect
consid
simpl
buyandhold
strategi
initi
long
posit
pharmaceut
portfolio
close
price
event
day
hold
day
unreport
result
confirm
strategi
would
also
yield
posit
outperform
period
examin
ew
vw
top
bottom
portfolio
averag
higher
perform
p
period
overal
find
invest
strategi
exploit
sentiment
fear
effect
relat
drn
lead
higher
profit
result
pronounc
bottom
portfolio
confirm
investor
sentiment
tend
greater
effect
small
cap
stock
motiv
abund
recent
behavior
financ
studi
show
particular
event
eg
st
patrick
day
arabisra
war
rosh
hashanah
intern
sport
game
may
strong
effect
investor
mood
investig
whether
drn
posit
signific
sentiment
effect
investor
interest
us
pharmaceut
compani
research
build
notion
vaccin
product
danger
infecti
diseas
concentr
larg
pharmaceut
compani
inde
number
vaccin
produc
us
decreas
dramat
last
four
decad
masignani
et
al
ration
investor
design
trade
strategi
base
expect
futur
cash
flow
compani
argu
ration
trade
occur
two
reason
first
wake
drn
uncertainti
surround
distant
cash
flow
vaccin
develop
may
high
second
resourc
smaller
pharmaceut
compani
may
limit
engag
largescal
r
instanc
typic
least
million
usd
need
develop
licens
new
pharmaceut
product
masignani
et
al
result
pharmaceut
stock
price
respond
drn
thu
drn
lead
higher
stock
price
return
pharmaceut
compani
alter
investor
sentiment
futur
perform
lead
irrat
trade
kaplanski
levi
potenti
neg
sentiment
effect
induc
fear
anxieti
due
drn
also
test
allow
us
account
two
conflict
sentiment
effect
find
period
drn
exert
posit
signific
effect
pharmaceut
firm
stock
return
effect
rel
stronger
portfolio
small
cap
stock
also
find
drn
effect
last
sever
day
consist
wide
held
view
drn
also
gener
panic
fear
anxieti
among
investor
observ
ad
hoc
fear
gaug
index
appear
exert
neg
signific
effect
return
pharmaceut
compani
stock
effect
stronger
small
rel
larg
cap
stock
research
show
larg
event
devast
natur
economi
consid
good
news
interest
group
stock
market
trader
overal
show
investor
optim
pessim
induc
drn
significantli
influenc
portfolio
invest
decis
pharmaceut
industri
find
utmost
import
practic
use
institut
individu
investor
portfolio
manag
financi
analyst
pharmaceut
firm
inde
identifi
rang
exploit
invest
opportun
end
design
number
trade
strategi
involv
portfolio
pharmaceut
stock
vix
result
exercis
unambigu
show
trade
strategi
yield
posit
signific
return
outcom
exercis
also
use
portfolio
manag
provid
advic
investor
financi
analyst
provid
comprehens
analysi
invest
opportun
pharmaceut
sector
furthermor
issu
sell
new
stock
investor
pharmaceut
firm
benefit
increas
market
valuat
henc
lower
cost
fund
r
spend
infecti
diseas
outbreak
occur
acceler
see
tabl
note
list
pharmaceut
compani
sort
market
capit
mcap
mcap
sampl
averag
analyz
period
million
usd
market
capit
share
compani
report
column
cap
weight
cum
sum
accumul
capit
last
column
show
capit
share
revers
order
ie
overal
capit
attribut
remain
firm
largest
firm
account
